Extracutaneous Lesions in Patients with Focal Scleroderma of Craniofacial Localization: a Retrospective Cross-Sectional Study

Extracutaneous Lesions in Patients with Focal Scleroderma of Craniofacial Localization: a Retrospective Cross-Sectional Study

Background. Focal scleroderma is rare, acquired disease characterized by inflammation, sclerosis, skin and underlying tissues atrophy, with no lesions to internal organs. However, craniofacial localized scleroderma (CLS) can lead to neurological, ophthalmic, and maxillofacial changes. Extracutaneous...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nikolay N. Murashkin, Alexander I. Materikin, Roman V. Epishev, Maria A. Leonova, Leonid A. Opryatin, Dmitry V. Fedorov, Roman A. Ivanov, Alena A. Savelova, Ekaterina S. Pavlova, Anastasiya U. Ufimtseva
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2024-11-01
Series:	Вопросы современной педиатрии
Subjects:	focal scleroderma linear scleroderma extracutaneous lesions magnetic resonance imaging neuroimaging
Online Access:	https://vsp.spr-journal.ru/jour/article/view/3600
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Etiopathogenetic Similarities of Combined Forms of Localized Scleroderma and Vitiligo
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Experience with Lipofilling in Children with Localized Scleroderma: Case Study
by: Alina R. Misbakhova, et al.
Published: (2024-11-01)

Clinical and Epidemiological Characteristics of Scleroderma in Children of the Samara Region: a Single-Stage Retrospective Study
by: Juliya S. Bogomolova, et al.
Published: (2025-05-01)

SCLERODERMA-LIKE MASK OF OSTEOPOIKILIA
by: R G Mukhina, et al.
Published: (2002-04-01)

Morphea profunda – a case report of deep localized scleroderma with severe thorax deformity
by: Natalia Tekiela, et al.
Published: (2025-01-01)

Face Lesions in En Coup De Sabre Scleroderma in Children: Modern Treatment and Outcomes Improvement
by: Nikolay N. Murashkin, et al.
Published: (2022-11-01)

Symptoms of Oesophageal Affection in Children With Scleroderma According to Mano-Impedancemetry: A Case Series
by: Marina Ju. Stepanyan, et al.
Published: (2019-02-01)

The problem of activity in systemic scleroderma
by: N G Guseva, et al.
Published: (2013-06-01)

Single Sitting Bilateral Dacryocystorhinostomy for Chronic Dacryocystitis in A Patient with Scleroderma and Bipolar Disorder
by: Tara Shruthi, et al.
Published: (2021-04-01)

Autoimmunity and Lymphoma: Splenic Marginal Zone Lymphoma with Scleroderma and Chronic Hepatitis C Virus infection.
by: Ricardo García-Muñoz
Published: (2014-08-01)

EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
by: E. I. Alexeeva, et al.
Published: (2012-05-01)

NEW CLASSIFICATION CRITERIA FOR SCLERODERMA SYSTEMATICA (a lecture)
by: Lidia Petrovna Ananyeva
Published: (2013-12-01)

Extracutaneous Manifestation of Ulcerative Colitis: Pyoderma Gangrenosum, A Case Report
by: Rohan Sapkota, et al.
Published: (2025-03-01)

Extracutaneous Manifestation of Ulcerative Colitis: Pyoderma Gangrenosum, A Case Report
by: Rohan Sapkota, et al.
Published: (2025-03-01)

Scleroderma-panniculitis: view of the rheumatologist
by: A. S. Potapova, et al.
Published: (2021-04-01)

Juvenile localized scleroderma: a large retrospective cohort study from a tertiary care center
by: Bugra Han Egeli, et al.
Published: (2025-06-01)

Neutrophil-to-lymphocyte ratio: association with microcirculatory changes detected by nailfold capillaroscopy in scleroderma patients and its relation to disease severity
by: Rasha M. Hammoda, et al.
Published: (2025-01-01)

THE CASE OF THE DEBUT OF SYSTEMIC SCLERODERMA IN A PATIENT AGED 10
by: А. V. BURLUTSKAYA, et al.
Published: (2018-07-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01)

EFFECT OF AT ORVASTATIN ON THE TIME COURSE OF CHANGESIN INFLAMMATORY MARKERS IN SYSTEMIC SCLERODERMA
by: R T Alekperov, et al.
Published: (2011-04-01)

Frequency of occurrenceof tumor-associated localized scleroderma
by: P. O. Kazakova
Published: (2025-05-01)

Scleroderma Renal Crisis as Initial Presentation of Scleroderma
by: Sahil Bagai, et al.
Published: (2022-04-01)

Linear Scleroderma and Neurological Complications
by: J Gordon Millichap
Published: (2006-01-01)

COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA
by: M N Starovoitova, et al.
Published: (2009-06-01)

Evaluation of the Efficiency of Treatment with Rituximab for Systemic Scleroderma (A Case Report)
by: E. N. Harlamova, et al.
Published: (2021-01-01)

Castleman’s Disease. Association with System Scleroderma
by: A. V. Yagoda, et al.
Published: (2023-10-01)

TUMOR-ASSOCIATED LOCALIZED SCLERODERMA IN CONJUNCTION WITH ACQIRED DISSIMINATED FORM OF VITILIGO: A CLINICAL CASE
by: A. S. Dvornikov, et al.
Published: (2017-03-01)

Neurological and psychological aspects of scleroderma of the face and neck in children
by: M. S. Pavlova, et al.
Published: (2021-06-01)

UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01)

Challenges in diagnosis and treatment of scleroderma renal crisis (clinical case report)
by: E. M. Mishina, et al.
Published: (2025-06-01)

Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics
by: Rinat K. Raupov, et al.
Published: (2020-06-01)

Fibrosing arthropathy in juvenile scleroderma
by: D. A. Dibrov, et al.
Published: (2021-04-01)

Use of the international systemic scleroderma activity index
by: Maya Nikolayevna Starovoitova, et al.
Published: (2013-03-01)

Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01)

DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
by: O. I. Emelyanova, et al.
Published: (2019-05-01)

The indicators of general clinical methods as prognostic markers of the severity of systemic scleroderma complicated by the development of pneumosclerosis.
by: O. V. Karaseva, et al.
Published: (2018-04-01)

IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)
by: Olga Aleksandrova Koneva
Published: (2010-06-01)

Late Diagnosis of Systemic Scleroderma with Vascular Events: Clinical Case
by: Julia S. Bogomolova, et al.
Published: (2024-12-01)

Сatalase antibodies in patients with systemic scleroderma as a diagnostic and prognostic marker of the disease
by: O. I. Emelyanova, et al.
Published: (2021-01-01)

Drug-induced fibrosing syndromes: A scoping review
by: Sakir Ahmed, et al.
Published: (2019-01-01)